Literature DB >> 21499767

Regulation of mammalian target of rapamycin complex 1 (mTORC1) by hypoxia: causes and consequences.

Hakan Cam1, Peter J Houghton.   

Abstract

Integration of cellular and extracellular signals maintains tissue homeostasis under conditions of normal proliferation and stress. A central player in regulating responses to stress is the serine/threonine kinase mammalian target of rapamycin (mTOR). In many cancers, mTOR complex 1 (mTORC1) signaling is enhanced, even under conditions where such signaling should be suppressed. This article reviews some of the details that are emerging on how low oxygen (hypoxia) regulates mTORC1 signaling, and the consequences for dysregulation in pediatric solid tumors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21499767     DOI: 10.1007/s11523-011-0173-x

Source DB:  PubMed          Journal:  Target Oncol        ISSN: 1776-2596            Impact factor:   4.493


  64 in total

1.  mTORC1 signaling under hypoxic conditions is controlled by ATM-dependent phosphorylation of HIF-1α.

Authors:  Hakan Cam; John B Easton; Anthony High; Peter J Houghton
Journal:  Mol Cell       Date:  2010-11-24       Impact factor: 17.970

2.  Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein.

Authors:  M E Cockman; N Masson; D R Mole; P Jaakkola; G W Chang; S C Clifford; E R Maher; C W Pugh; P J Ratcliffe; P H Maxwell
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

3.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

4.  Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks.

Authors:  D Cortez; Y Wang; J Qin; S J Elledge
Journal:  Science       Date:  1999-11-05       Impact factor: 47.728

5.  Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro.

Authors:  S Matsuoka; G Rotman; A Ogawa; Y Shiloh; K Tamai; S J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

6.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.

Authors:  Jirina Bartkova; Zuzana Horejsí; Karen Koed; Alwin Krämer; Frederic Tort; Karsten Zieger; Per Guldberg; Maxwell Sehested; Jahn M Nesland; Claudia Lukas; Torben Ørntoft; Jiri Lukas; Jiri Bartek
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

7.  A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets.

Authors:  Andrew M Arsham; Jessica J Howell; M Celeste Simon
Journal:  J Biol Chem       Date:  2003-05-30       Impact factor: 5.157

8.  Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase.

Authors:  Philippe P Roux; Bryan A Ballif; Rana Anjum; Steven P Gygi; John Blenis
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-01       Impact factor: 11.205

9.  JunD reduces tumor angiogenesis by protecting cells from oxidative stress.

Authors:  Damien Gerald; Edurne Berra; Yves M Frapart; Denise A Chan; Amato J Giaccia; Daniel Mansuy; Jacques Pouysségur; Moshe Yaniv; Fatima Mechta-Grigoriou
Journal:  Cell       Date:  2004-09-17       Impact factor: 41.582

10.  Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex.

Authors:  James Brugarolas; Kui Lei; Rebecca L Hurley; Brendan D Manning; Jan H Reiling; Ernst Hafen; Lee A Witters; Leif W Ellisen; William G Kaelin
Journal:  Genes Dev       Date:  2004-11-15       Impact factor: 11.361

View more
  14 in total

1.  Are we ready to move away from nature?: the rapamycin story.

Authors:  Monica Mita; Alain Mita
Journal:  Target Oncol       Date:  2011-06-15       Impact factor: 4.493

2.  Targeting the target of rapamycin (TOR): looking to mother nature.

Authors:  Eric K Rowinsky
Journal:  Target Oncol       Date:  2011-04-27       Impact factor: 4.493

Review 3.  DEPTOR ubiquitination and destruction by SCF(β-TrCP).

Authors:  Zhiwei Wang; Jiateng Zhong; Daming Gao; Hiroyuki Inuzuka; Pengda Liu; Wenyi Wei
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-03-27       Impact factor: 4.310

Review 4.  The resolution of ambiguity as the basis for life: A cellular bridge between Western reductionism and Eastern holism.

Authors:  John S Torday; William B Miller
Journal:  Prog Biophys Mol Biol       Date:  2017-07-22       Impact factor: 3.667

5.  Andes virus infection of lymphatic endothelial cells causes giant cell and enhanced permeability responses that are rapamycin and vascular endothelial growth factor C sensitive.

Authors:  Irina N Gavrilovskaya; Elena E Gorbunova; Erich R Mackow
Journal:  J Virol       Date:  2012-06-13       Impact factor: 5.103

Review 6.  Autophagy in hypoxic ovary.

Authors:  Anil Kumar Yadav; Pramod K Yadav; Govind R Chaudhary; Meenakshi Tiwari; Anumegha Gupta; Alka Sharma; Ashutosh N Pandey; Ajai K Pandey; Shail K Chaube
Journal:  Cell Mol Life Sci       Date:  2019-05-06       Impact factor: 9.261

7.  Hypoxia induces permeability and giant cell responses of Andes virus-infected pulmonary endothelial cells by activating the mTOR-S6K signaling pathway.

Authors:  Irina N Gavrilovskaya; Elena E Gorbunova; Erich R Mackow
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

Review 8.  mTOR Signaling as a Regulator of Hematopoietic Stem Cell Fate.

Authors:  Hélia Fernandes; João Moura; Eugénia Carvalho
Journal:  Stem Cell Rev Rep       Date:  2021-02-14       Impact factor: 6.692

9.  DDIT4/REDD1/RTP801 is a novel negative regulator of Schwann cell myelination.

Authors:  Roberta Noseda; Sophie Belin; Françoise Piguet; Ilaria Vaccari; Stefania Scarlino; Paola Brambilla; Filippo Martinelli Boneschi; Maria Laura Feltri; Lawrence Wrabetz; Angelo Quattrini; Elena Feinstein; Richard L Huganir; Alessandra Bolino
Journal:  J Neurosci       Date:  2013-09-18       Impact factor: 6.167

10.  Small molecules inhibitors of the heterogeneous ribonuclear protein A18 (hnRNP A18): a regulator of protein translation and an immune checkpoint.

Authors:  Eduardo Solano-Gonzalez; Katherine M Coburn; Wenbo Yu; Gerald M Wilson; Elmar Nurmemmedov; Santosh Kesari; Elizabeth T Chang; Alexander D MacKerell; David J Weber; France Carrier
Journal:  Nucleic Acids Res       Date:  2021-02-22       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.